A carregar...
Neutralization of the CD95 ligand by APG101 inhibits invasion of glioma cells in vitro
Glioblastoma is a disease characterized by rapid invasive tumour growth. Studies on the proapoptotic CD95/CD95L signalling pathway recently suggested a significant contribution of CD95 signalling towards the high degree of motility in glioma cells. Apogenix has developed APG101, a clinical phase II...
Na minha lista:
| Publicado no: | Anticancer Drugs |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4484665/ https://ncbi.nlm.nih.gov/pubmed/25850884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000237 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|